No Photo Available

Last Update

2016-11-01T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Stephen Martin?

Dr. Stephen M. Martin

President Emeritus

QSpex Technologies Inc

Direct Phone: (770) ***-****       

Email: s***@***.com

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

QSpex Technologies Inc

1525 BLUEGRASS LAKES PKWY

Alpharetta, Georgia 30004

United States

Company Description

About QSpex Technologies, Inc. - QSpex Technologies, Inc. founded in 2007 is based on proprietary technology created by Dr. Kai Su, Founder and Chief Scientific Officer. The company's mission is to offer vision care providers the unique capability to incr ... more

Find other employees at this company (190)

Background Information

Employment History

Chief Executive Officer Partner

Hi Tech Partners , LLC

Director of Public Affairs

Kentucky National Guard

Oncology Account Manager

Novartis AG

Head of Global Pharma Research and Development

Merial Limited

Head, Biopharm Discovery

GlaxoSmithKline plc

Head, Analytical Sciences

NIBR

Affiliations

Board Member
OcuCure Therapeutics , Inc.

Board Member
La Jolla Pharmaceutical Company

Board Member
Alimera Sciences Inc

Board Member
NeoVista , Inc.

Board Member
Accuitis Inc

Founder
Novartis Vaccines Inc

Founder
CIBA Vision Corporation

Education

Wake Forest University

Woodrow Wilson College of Law

Ph.D.

Web References (79 Total References)


Partners – Hi Tech Partners

hitechpartners.com [cached]

Steve Martin,

...
Steve Martin CEO Partner
Steve Martin founded CIBA VISION Optics in 1980 and CIBA Vision Ophthalmics (now Novartis Ophthalmics) in 1990. He and his team grew sales of the combined companies to over $1.2 Billion with more than 6,000 employees.
CIBA Vision is a world leader in research, development, manufacture and marketing of soft contact lenses, lens-care products and ophthalmic pharmaceuticals. CIBA Vision markets in nearly 90 countries. Steve was President of CIBA Vision Corporation USA until 1998.
Until his retirement in June 2001 Steve acted as a venture opportunity liaison on entrepreneurial life science projects for Swiss giant Novartis. He continues to help entrepreneurs find venture capital funding through Merritt Capital Services where he is a General Partner. Steve has successfully negotiated more than 70 licensing and acquisition deals with values ranging from $1 million to $320 million.
Steve's worldwide business contacts include decision makers in organizations such as ALZA, Bank of America Ventures (now Scale Venture Partners), Bausch & Lomb, Cordova Ventures, Domain Associates, Essex Woodlands Health Ventures, The FDA, Frazier Healthcare Ventures, InterSouth Partners, Johnson & Johnson, Kleiner-Perkins, Merck, MPM Capital, The Nobel Foundation, Noro-Moseley Partners, Polaris Ventures, and Solvay Pharmaceuticals. He has served on the board of directors for numerous public and private companies. Currently, he is on the board of La Jolla Pharmaceutical Company (LJPC-NASDAQ), NeoVista, Inc. (private) and OcuCure Therapeutics, Inc. (private). Steve also is an advisor to the CEOs of QSpex, Encompass Pharmaceutical Services, Apeliotus Technologies, and Visioneering.
Steve is a graduate of Wake Forest University and attended the Woodrow Wilson College of Law. He served as a Captain in the United States Marine Corps. Steve holds six U.S. Patents issued for his inventions and a number of European Patents. He and his wife Judy now live in the North Georgia Mountains.


Accuitis Pharmaceuticals, Inc - About Us

www.accuitis.com [cached]

Steve Martin over 34 years experience in the ophthalmic pharmaceutical and medical device industry. He joined the board of QSpex Technologies in July 2008 and briefly served as QSpex' Chief Business Office before taking on the CEO responsibility for QSpex in May 2009. Previously, Steve founded CIBA VISION Optics in 1980 and CIBA Vision Ophthalmics (now Novartis Ophthalmics) in 1990. He and his team grew sales of the combined companies to over $1.3 Billion with more than 6,000 employees. CIBA Vision is a world leader in research, development, manufacture and marketing of soft contact lenses, lens-care products and ophthalmic pharmaceuticals. Mr. Martin was President of CIBA Vision Corporation USA until 1998. Steve has personally successfully negotiated more than 70 licensing and acquisition deals with values ranging from $1 million to $320 million. He has assisted several start-ups in raising equity capital. He has served as a director on the boards of numerous public and private companies. Steve currently is a director of La Jolla Pharmaceutical Company (publicly traded), OcuCure Therapeutics (private), NeoVista, Inc. (private) and QSpex Technologies, Inc. (private). Steve is a graduate of Wake Forest University and attended the Woodrow Wilson College of Law. He holds 6 issued U.S. Patents for his inventions and a number of European patents. Steve was a Captain in the United States Marine Corps.??


Hi Tech Partners - Partners

www.hitechpartners.com [cached]

Steve Martin, CEO Partner

Steve Martin, (678) 367-6492 x703 CEO Partner stevem@hitechpartners.com
Steve Martin founded CIBA VISION Optics in 1980 and CIBA Vision Ophthalmics (now Novartis Ophthalmics) in 1990. He and his team grew sales of the combined companies to over $1.2 Billion with more than 6,000 employees.
CIBA Vision is a world leader in research, development, manufacture and marketing of soft contact lenses, lens-care products and ophthalmic pharmaceuticals. CIBA Vision markets in nearly 90 countries. Steve was President of CIBA Vision Corporation USA until 1998.
Until his retirement in June 2001 Steve acted as a venture opportunity liaison on entrepreneurial life science projects for Swiss giant Novartis. He continues to help entrepreneurs find venture capital funding through Merritt Capital Services where he is a General Partner. Steve has successfully negotiated more than 70 licensing and acquisition deals with values ranging from $1 million to $320 million.
Steve's worldwide business contacts include decision makers in organizations such as ALZA, Bank of America Ventures (now Scale Venture Partners), Bausch & Lomb, Cordova Ventures, Domain Associates, Essex Woodlands Health Ventures, The FDA, Frazier Healthcare Ventures, InterSouth Partners, Johnson & Johnson, Kleiner-Perkins, Merck, MPM Capital, The Nobel Foundation, Noro-Moseley Partners, Polaris Ventures, and Solvay Pharmaceuticals. He has served on the board of directors for numerous public and private companies. Currently, he is on the board of La Jolla Pharmaceutical Company (LJPC-NASDAQ), NeoVista, Inc. (private) and OcuCure Therapeutics, Inc. (private). Steve also is an advisor to the CEOs of QSpex, Encompass Pharmaceutical Services, Apeliotus Technologies, and Visioneering.
Steve is a graduate of Wake Forest University and attended the Woodrow Wilson College of Law. He served as a Captain in the United States Marine Corps. Steve holds six U.S. Patents issued for his inventions and a number of European Patents. He and his wife Judy now live in the North Georgia Mountains.


"Kevin brings significant industry and ...

www.2020mag.com [cached]

"Kevin brings significant industry and management experience to QSpex, which is beneficial now that we are actively launching our innovative QSpex Premium Lens System into offices across the U.S.," comments QSpex CEO Steve Martin.


QSpex® Technologies, Inc. Introduces Kevin Bligh as VP of Sales and Marketing |

opticalvisionresources.com [cached]

Alpharetta, Georgia - Steve Martin, CEO of QSpex Technologies, Inc. has announced that industry veteran Kevin Bligh recently joined their senior management team as Vice President of Sales and Marketing.

...
"Kevin brings significant industry and management experience to QSpex, which is beneficial now that we are actively launching our innovative QSpex Premium Lens System into offices across the U.S."' commented Mr. Martin.
...
The company is led by CEO Steve Martin, an industry innovator whose many accomplishments include founding CIBA Vision in 1980 and CIBA Vision Ophthalmics in 1990.

Similar Profiles

Other People with this Name

Other people with the name Martin

Daniel Martin
en world group

Lester Martin
Crown Furniture

Dave Martin
Arup bv

Steven Martin
American Reprographics Company

Debra Martin
GCM Insurance & Risk Management LLC

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory